Regan Andrew (CIK 1991325) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy CDT (5.4M shares), Sell CDT (290 shares), Buy CDT (147,401 shares), Buy CDT (100,000 shares), Buy CDT (224,800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | CDT Equity Inc. (CDT) | Chief Executive Officer | Buy | 5.4M | $0 |
| 2026-09-02 | CDT Equity Inc. (CDT) | Chief Executive Officer | Sell | 290 | $0 |
| 2026-05-14 | CDT Equity Inc. (CDT) | Chief Executive Officer | Buy | 147,401 | $0 |
| 2026-05-14 | CDT Equity Inc. (CDT) | Chief Executive Officer | Buy | 100,000 | $190,000 |
| 2025-12-22 | CDT Equity Inc. (CDT) | Chief Executive Officer | Buy | 224,800 | $402,392 |
| 2025-09-22 | CDT Equity Inc. (CDT) | Chief Executive Officer | Buy | 1.1M | $772,800 |
| 2025-06-13 | CONDUIT PHARMACEUTICALS INC. (CDT) | Chief Executive Officer | Buy | 154,799 | $500,001 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02